Passa al contenuto
Merck
Tutte le immagini(1)

Documenti

C3866

Sigma-Aldrich

Anti-Calcitonin Receptor-Like Receptor antibody produced in rabbit

affinity isolated antibody, buffered aqueous solution

Autenticatiper visualizzare i prezzi riservati alla tua organizzazione & contrattuali
Tutte le immagini(1)

About This Item

Numero MDL:
MFCD06798428
Codice UNSPSC:
12352203
NACRES:
NA.41

Origine biologica

rabbit

Livello qualitativo

200

Coniugato

unconjugated

Forma dell’anticorpo

affinity isolated antibody

Tipo di anticorpo

primary antibodies

Clone

polyclonal

Forma fisica

buffered aqueous solution

Reattività contro le specie

human

Disponibilità

not available in Japan

tecniche

immunohistochemistry (formalin-fixed, paraffin-embedded sections): 7.5 μg/mL using human arterial smooth muscle

N° accesso UniProt

Q16602

Condizioni di spedizione

dry ice

Temperatura di conservazione

−20°C

Informazioni sul gene

human ... CALCRL(10203)
mouse ... Calcrl(54598)
rat ... Calcrl(25029)

Immunogeno

synthetic peptide corresponding to the first extracellular loop of human calcitonin receptor-like receptor, conjugated to KLH. The immunizing peptide has 100% homology with the rat and mouse gene.

Applicazioni

Anti-Calcitonin Receptor-Like Receptor antibody produced in rabbit was used for immunocytochemistry of mouse bone marrow-derived mucosal mast cells at a dilution of 1:100.

Azioni biochim/fisiol

Calcitonin receptor-like receptor (CLR) is a G protein-coupled receptor that binds receptor-activity-modifying proteins (RAMP)1, -2 and -3. CLR has been implicated in conditions such as obesity, diabetes, osteoporosis, migraine and cardiovascular disease.

Stato fisico

Solution in phosphate buffered saline containing ≤ 0.1% sodium azide.

Esclusione di responsabilità

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Non trovi il prodotto giusto?  

Prova il nostro Motore di ricerca dei prodotti.

Codice della classe di stoccaggio

10 - Combustible liquids

Classe di pericolosità dell'acqua (WGK)

nwg

Punto d’infiammabilità (°F)

Not applicable

Punto d’infiammabilità (°C)

Not applicable

Certificati d'analisi (COA)

Cerca il Certificati d'analisi (COA) digitando il numero di lotto/batch corrispondente. I numeri di lotto o di batch sono stampati sull'etichetta dei prodotti dopo la parola ‘Lotto’ o ‘Batch’.

Possiedi già questo prodotto?

I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.

Visita l’Archivio dei documenti

J W Rychter et al.
Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society, 23(2), e57-e68 (2010-10-23)
The parasitized or inflamed gastrointestinal mucosa shows an increase in the number of mucosal mast cells (MMC) and the density of extrinsic primary afferent nerve fibers containing the neuropeptide, calcitonin gene-related peptide (CGRP). Currently, the mode of action of CGRP
James Barwell et al.
British journal of pharmacology, 166(1), 51-65 (2011-06-09)
The calcitonin receptor (CTR) and calcitonin receptor-like receptor (CLR) are two of the 15 human family B (or Secretin-like) GPCRs. CTR and CLR are of considerable biological interest as their pharmacology is moulded by interactions with receptor activity-modifying proteins. They
Eric L Moore et al.
British journal of pharmacology, 166(1), 66-78 (2011-08-30)
The clinical effectiveness of antagonizing the calcitonin gene-related peptide (CGRP) receptor for relief of migraine pain has been clearly demonstrated, but the road to the development of these small molecule antagonists has been daunting. The key hurdle that needed to
Rikke R Hansen et al.
Pain, 157(3), 666-676 (2015-11-18)
Severe pain is a common and debilitating complication of metastatic bone cancer. Current analgesics provide insufficient pain relief and often lead to significant adverse effects. In models of cancer-induced bone pain, pathological sprouting of sensory fibers at the tumor-bone interface

Il team dei nostri ricercatori vanta grande esperienza in tutte le aree della ricerca quali Life Science, scienza dei materiali, sintesi chimica, cromatografia, discipline analitiche, ecc..

Contatta l'Assistenza Tecnica.